FSSAI Advisory On Raising Grievances Related To Central Licences’ Plea

New Delhi : The FSSAI has issued an advisory explaining the matrix for raising grievances/queries related to Central licences’ applications.

The advisory says that in case any food business operator (FBO) is aggrieved by the decision by the Central licensing authority, the matter can be escalated to the concerned Regional Director while in case the FBO further wants to represent the case after receiving comments from the concerned Regional Director or in case no comments was received within 21 days from raising the request to the concerned RD, the FBO can escalate the matter before Executive Director Compliance Strategy at FSSAI Headquarters along with all the relevant communication made with respect to the case till date.

The FSSAI has also advised that communication should be made through registered email id as provided in the licensing application by the FBO.

It is pertinent to note that FSSAI has an online platform, the Food Safety Compliance System (FoSCoS) for issuance of pan-India FSSAI licence and registration and for Central licensing procedures as laid down under the FSS Act, the food authority has approved Central Licensing Authority (CLA).

  • Related Posts

    • Pharma
    • July 26, 2024
    • 126 views
    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

    • Pharma
    • July 26, 2024
    • 125 views
    Indian National Charged With Selling Counterfeit Cancer Drugs

    HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    Indian National Charged With Selling Counterfeit Cancer Drugs

    Indian National Charged With Selling Counterfeit Cancer Drugs

    ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

    ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

    BIS Sanctioned 82 Medical Device Projects To Develop Standards

    BIS Sanctioned 82 Medical Device Projects To Develop Standards

    Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

    Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

    ‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

    ‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD